Astaxanthin mediated regulation of VEGF through HIF1α and XBP1 signaling pathway: An insight from ARPE-19 cell and streptozotocin mediated diabetic rat model. (May 2021)

• Record Type: Journal Article
• Authors: Janani, Rajasekar; Anitha, Rani Elavarasan; Perumal, Madan Kumar; Divya, Peethambaran; Baskaran, Vallikannan
• Is Part Of: Experimental eye research. Volume 206(2021)
• Publication Date: 2021-05
• Subjects: Astaxanthin -- Human retinal pigment epithelial (RPE) cells -- Hyperglycemia -- Hypoxia -- Vascular endothelial growth factor (VEGF); BRB Blood-retina barrier -- CoCl2 Cobalt chloride -- DME Diabetic macular edema -- DR Diabetic retinopathy -- ER Endoplasmic reticulum -- HG Hyperglycemic condition -- HIF1α Hypoxia-inducible factor 1α -- RPE Retinal pigment epithelial cells -- VEGF Vascular endothelial growth factor -- XBP1 X-box binding protein 1 -- ZO-1 Zona occludin-1; Ophthalmology -- Periodicals; Eye -- Periodicals; Œil -- Périodiques; Ophthalmology; Periodicals; Electronic journals; 612.8405
• DOI: 10.1016/j.exer.2021.108555
• Languages: English
• ISSNs: 0014-4835

Abstract

Abstract: Breakdown of outer blood-retina barrier (BRB) has been associated with the pathogenesis of diabetic retinopathy (DR) and diabetic macular edema (DME). Vascular endothelial growth factor (VEGF) might play a detrimental role in the pathogenesis of DME, a major clinical manifestation of DR. In the present study, we investigated the inhibitory mechanism of astaxanthin on VEGF and its upstream signaling pathways under in vitro and in vivo conditions. Astaxanthin has been observed to downregulate VEGF expression under hyperglycemic (HG) and CoCl2 induced hypoxic conditions in ARPE-19 cells. There were compelling pieces of evidence for the involvement of transcription factors like HIF1α and XBP1 in the upregulation of VEGF under HG and hypoxic conditions. Thus, we investigated the role of astaxanthin in the expression and nuclear translocation of HIF1α and XBP1. The activation and translocation of HIF1α and XBP1 induced by HG or CoCl2 conditions were hindered by astaxanthin. Additionally, treatment with HIF1α siRNA and IRE1 inhibitor STF-083010 also inhibited the expression of VEGF induced by HG and CoCl2 conditions. These results indicated that the anti-VEGF property of astaxanthin might be associated with the downregulation of HIF1α and XBP1. Furthermore, astaxanthin mitigated the enhanced migration of retinal pigment epithelial (RPE) cells under DR conditions. As well, astaxanthin protected disorganization of zona occludin-1 (ZO-1) tight junction protein in RPE and reduced HG or hypoxic induced permeability of RPE cells. In streptozotocin-induced diabetic rat model, astaxanthin reduced the expression of HIF1α, XBP1, and VEGF as well as protected the abnormalities in the retinal layers induced by diabetes condition. Thus, astaxanthin may be used as a potential nutraceutical to prevent or treat retinal dysfunction in diabetic patients. Graphical abstract: Image 1 Highlights: Under hyperglycemic (HG) or hypoxic condition, astaxanthin suppressed the VEGF expression by downregulating HIF1α and XBP1 in ARPE-19 cell and retina of diabetic rats. Astaxanthin protected the structural integrity of RPE cells by protecting tight junction protein (ZO-1) and reduced the HG/hypoxia induced RPE permeability. Astaxanthin modulated the diabetes induced retinal morphological changes. Astaxanthin can serve as a beneficial nutritional supplement in the treatment of DR.